DRUG STUDY Name of Dose, Classification Mechanism of Indication Contraindication Side effect Nursing Drugs Route, Action Responsibilities Frequency Antipsychotics, The activity of Contraindicated in Dizziness/low Encourage patient Olanzapine 10mg / 2nd olanzapine is Olanzapine was patients with a blood pressure to void before Oral / OD Generation; achieved by the initially used known upon standing taking the drug to HS Antimanic antagonism of orally and hypersensitivity to Weight gain, help decrease Agents multiple intramuscularly the product. May dose dependent anticholinergic neuronal for the chronic exacerbate, High levels of effects of urinary receptors treatment of possibly triglycerides in retention. Monitor including the schizophrenia precipitate, the blood for elevations of dopamine in patients over diabetes mellitus, High cholesterol temperature and receptor D1, D2, 13 years old low white blood cell Drowsiness, differentiate D3 and D4 in the and other count or liver dose dependent between infection brain, the psychiatric dysfunction. Extrapyramidal and neuroleptic serotonin disorders such Caution in symptoms (EPS), malignant receptors as bipolar I galactosemia and dose dependent syndrome. Monitor 5HT2A, 5HT2C, disorder phenylketonuria (muscle spasms, for orthostatic 5HT3 and 5HT6, including due to excipients. jerky hypotension and the alpha-1 mixed or manic movements, slow provide appropriate adrenergic episodes. movements) safety measures as receptor, the Olanzapine is Dry mouth needed. histamine also indicated, Weakness receptor H1 and in combination Dizziness multiple with lithium or Accidental injury muscarinic valproate for Insomnia receptors. the short-term Elevated alanine On the other treatment of aminotransferase hand, olanzapine acute manic or (ALT) level acts in the mixed episodes Constipation serotonin 5HT2A associated with Indigestion receptors in the bipolar I Elevated levels frontal cortex in disorder in of prolactin in a similar manner adults. the blood than the As well, High blood sugar reported on olanzapine is Low blood dopamine D2 indicated, in pressure receptors. This combination Tremor determined with fluoxetine Weakness effect allows for for the Restlessness a decrease in treatment of Parkinsonism adverse effects. episodes of reactions depression associated with bipolar disorder type 1 and treatment- resistant depression in patients over 10 years old